|
NDUFS7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.387200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.326200E-01 |
| Normal-vs-Stage2 |
1.958030E-01 |
| Normal-vs-Stage3 |
2.163600E-01 |
| Normal-vs-Stage4 |
5.113800E-01 |
| Stage1-vs-Stage2 |
1.334650E-01 |
| Stage1-vs-Stage3 |
9.014200E-02 |
| Stage1-vs-Stage4 |
3.405200E-01 |
| Stage2-vs-Stage3 |
9.889600E-01 |
| Stage2-vs-Stage4 |
8.794800E-01 |
| Stage3-vs-Stage4 |
8.900800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.610600E-01 |
| Normal-vs-AfricanAmerican |
8.572800E-01 |
| Normal-vs-Asian |
9.061400E-01 |
| Caucasian-vs-AfricanAmerican |
4.712400E-01 |
| Caucasian-vs-Asian |
7.213000E-01 |
| AfricanAmerican-vs-Asian |
9.362000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.291400E-01 |
| Normal-vs-Female |
4.110400E-01 |
| Male-vs-Female |
4.422800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.406600E-01 |
| Normal-vs-Extreme_Weight |
2.163800E-01 |
| Normal-vs-Obese |
3.051400E-01 |
| Normal-vs-Extreme_Obese |
1.953960E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.176800E-01 |
| Normal_Weight-vs-Obese |
4.804800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.672600E-01 |
| Extreme_Weight-vs-Obese |
3.387900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.922800E-01 |
| Obese-vs-Extreme_Obese |
1.444210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.531200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.203420E-01 |
| Normal-vs-Age(61-80Yrs) |
4.813200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.770600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.608400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.747800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.937000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.245940E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.538200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.117200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.710400E-01 |
| Normal-VS-Type2 PRCC |
8.465200E-01 |
| Normal-VS-KIRP CIMP |
1.99446999999964E-05 |
| Normal-VS-Unclassified PRCC |
8.620200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.233600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.399700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.894200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.419620E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.786400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.616900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.494400E-01 |
| Normal-vs-N1 |
2.996900E-03 |
| Normal-vs-N2 |
2.290000E-02 |
| N0-vs-N1 |
1.521090E-03 |
| N0-vs-N2 |
6.963800E-02 |
| N1-vs-N2 |
8.367800E-01 |
|
|
